← Leaderboards
Goldis Malek
Duke University
$10,013,248
Attributed
$10,013,248
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,013,248 · 8
By mechanism
R01$8,717,988 · 5
P30$1,295,260 · 3
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Catherine Bowes Rickman$11,208,971
- Glenn Jaffe$4,863,463
- Sina Farsiu$7,258,300
- Katherine J. Franz$5,329,319
- Jennifer L. Ingram$3,055,195
Others in their field
Top investigators on “Pathology”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologyGeneticMorphologyBlindnessIn VivoPathway InteractionsAge Related Macular DegenerationIn VitroSignal PathwayWestern WorldGrantLipidsAffectDepositionCellsFunctional DisorderAnimal ModelVisionLigandsPreventLinkProteinsMouse ModelDesign
Grant awards (30)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration$459,739
R01 · FY2025 · EY · contact PI
Animal Models Module$148,638
P30 · FY2025 · EY · contact PI
Nuclear receptor driven mechanisms in aging and AMD$472,677
R01 · FY2024 · EY · contact PI
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration$459,739
R01 · FY2024 · EY · contact PI
Animal Models Module$148,638
P30 · FY2024 · EY · contact PI
Nuclear receptor driven mechanisms in aging and AMD$472,677
R01 · FY2023 · EY · contact PI
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration$454,667
R01 · FY2023 · EY · contact PI
Animal Models Module$148,638
P30 · FY2023 · EY · contact PI
Nuclear receptor driven mechanisms in aging and AMD$458,497
R01 · FY2022 · EY · contact PI
Animal Models Module$148,638
P30 · FY2022 · EY · contact PI
Novel signaling pathways regulated by the liver x receptor in age-related macular degeneration$470,657
R01 · FY2021 · EY · contact PI
Nuclear receptor driven mechanisms in aging and AMD$432,544
R01 · FY2021 · EY · contact PI
Regulation of inflammation and lipid homeostasis by the aryl hydrocarbon receptor in age-related macular degeneration$424,100
R01 · FY2021 · EY · contact PI
Animal Models Module$148,638
P30 · FY2021 · EY · contact PI
Novel signaling pathways regulated by the liver x receptor in age-related macular degeneration$485,214
R01 · FY2020 · EY · contact PI
Regulation of inflammation and lipid homeostasis by the aryl hydrocarbon receptor in age-related macular degeneration$437,215
R01 · FY2020 · EY · contact PI
Animal Models Core$110,414
P30 · FY2020 · EY · contact PI
Novel signaling pathways regulated by the liver x receptor in age-related macular degeneration$484,209
R01 · FY2019 · EY · contact PI
Regulation of inflammation and lipid homeostasis by the aryl hydrocarbon receptor in age-related macular degeneration$448,962
R01 · FY2019 · EY · contact PI
Animal Models Core$110,414
P30 · FY2019 · EY · contact PI
Novel signaling pathways regulated by the liver x receptor in age-related macular degeneration$481,195
R01 · FY2018 · EY · contact PI
Regulation of inflammation and lipid homeostasis by the aryl hydrocarbon receptor in age-related macular degeneration$444,346
R01 · FY2018 · EY · contact PI
Animal Models Core$110,414
P30 · FY2018 · EY · contact PI
Animal Models Core$110,414
P30 · FY2017 · EY · contact PI
Animal Models Core$110,414
P30 · FY2016 · EY · contact PI
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration$338,154
R01 · FY2015 · EY · contact PI
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration$337,592
R01 · FY2014 · EY · contact PI
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration$364,831
R01 · FY2013 · EY · contact PI
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration$398,473
R01 · FY2012 · EY · contact PI
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration$392,500
R01 · FY2011 · EY · contact PI